Mesalamine: Clinical Trials

34 trials of Mesalamine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

20 completed, 8 recruiting, 3 unknown, 1 active not recruiting. 34 Phase 2, 7 Phase 3, 4 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 234Completed 20, Recruiting 8, Unknown 3, Active not recruiting 1, Terminated 1, Withdrawn 1
Phase 37Completed 5, Recruiting 1, Unknown 1
Phase 14Completed 2, Active not recruiting 1, Unknown 1

Follow Mesalamine: new trials by email Literature Review of Mesalamine trials Research Report on Mesalamine

Trials (filtered) newest first · largest first

All 34 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Desloratadine in Patients With Ulcerative Colitis
Desloratadine, mesalamine - Ulcerative Colitis (UC), Ulcerative Colitis
Phase 2RecruitingTanta University442026-01-262026-01-29
Pentoxifylline in Patients With Ulcerative Colitis
Mesalamine, Pentoxifylline - Inflammatory Bowel Diseases
Phase 2RecruitingIhab Elsayed Hassan602026-01-202026-04-15
Rupatadine in Patients With Ulcerative Colitis
Mesalamine, Rupatadine - Ulcerative Colitis
Phase 2RecruitingAlexandria University602025-07-152025-11-19
Nitazoxanide in Patients With Ulcerative Colitis
Mesalamine, Nitazoxanide - Ulcerative Colitis
Phase 2RecruitingAlexandria University702025-05-302025-06-27
Beneficial Effect of Silymarin in Ulcerative Colitis
Silymarin, Mesalamine, Azathioprine - Ulcerative Colitis
Phase 2RecruitingTanta University442025-02-012025-03-05
Prophylactic Mesalamine to Prevent Colitis Following Treatment With Ipilimumab/Nivolumab (Ipi/Nivo)
Mesalamine - Immune-related Adverse Event, Diarrhea
Phase 2RecruitingAHS Cancer Control Alberta202024-08-202026-11-04
Minocyclin in Ulcerative Colitis as Added on Therapy
Mesalazine, Minocycline - Inflammatory Bowel Diseases
Phase 2CompletedMostafa Bahaa462024-01-222025-11-18
Dapagliflozin in Patients With Ulcerative Colitis
Mesalamine, Dapagliflozin 10mg Tab - Inflammatory Bowel Diseases
Phase 2 / Phase 3CompletedMostafa Bahaa602023-08-202026-09-21
Clinical Study to Evaluate the Possible Efficacy of Nifuroxazide in Patient With Ulcerative Colitis
Mesalamine, Nifuroxazide - Inflammatory Bowel Diseases
Phase 2 / Phase 3CompletedMostafa Bahaa502023-08-202026-10-13
Repurposing Fenofibrate in Modulating AMPK/NLRP3 Inflammasome in Patients With Ulcerative Colitis
Mesalamine, Fenofibrate - Inflammatory Bowel Diseases
Phase 2CompletedTanta University702023-03-202026-10-13
Fenofibrate in Ulcerative Colitis
Mesalamine, Fenofibrate 160mg - Inflammatory Bowel Diseases
Phase 2 / Phase 3CompletedTanta University602023-02-282026-05-04
Atorvastatin Efficacy and Safety in Patients With Ulcerative Colitis
Atorvastatin 80mg, Mesalamine - Inflammatory Bowel Diseases
Phase 2CompletedTanta University542023-02-012025-11-18
Administration of Hydroxychloroquine (Plaquenil) to African Americans and Hispanics for the Treatment of Mild to Severe Ulcerative Colitis
Hydroxychloroquine, Mesalamine - Ulcerative Colitis (Disorder)
Phase 1 / Phase 2Active not recruitingIcahn School of Medicine at Mount Sinai32022-06-102025-02-11
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
Mesalamine, Placebo - Lynch Syndrome, Colon Cancer
Phase 2RecruitingAnn-Sofie Backman1502022-03-212024-12-17
Fecal Microbiota Transplantation for Ulcerative Colitis
Fecal microbiota transplantation, Infusion of Saline, 5-Aminosalicylic acid(5-ASA) and/or Prednisone - Ulcerative Colitis, Fecal Microbiota Transplantation
Phase 2 / Phase 3RecruitingGuangzhou First People's Hospital1202019-01-202019-01-15
Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome
mesalamine 2400 MG (5-ASA), mesalamine 1200 MG, Placebo - Colorectal Cancer
Phase 2TerminatedChristoph Gasche82017-11-242019-04-18
Faecal Bacteriotherapy for Ulcerative Colitis
Faecal bacterial transplantation, Mesalazine 4G Enema - Ulcerative Colitis
Phase 2CompletedInstitute for Clinical and Experimental Medicine612017-06-192021-10-01
Standardized Fecal Microbiota Transplantation for Inflammatory Bowel Disease
FMT, Mesalazine - Inflammatory Bowel Disease, Ulcerative Colitis
Phase 2UnknownYanling Wei402015-01-012015-01-09
Role of Intestinal Protozoa and Helminths in the Course of Ulcerative Colitis
parasitological diagnostics (coproscopy), Nitazoxanide 500Mg Oral Tablet, Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet - Ulcerative Colitis, Ulcerative Colitis Exacerbation
Phase 1 / Phase 2UnknownResearch Institute of Epidemiology, Microbiology and Infectious Diseases, Uzbekistan3002015-01-012023-03-03
Efficacy and Safety Study of Tripterygium Glycoside in the Treatment of Crohn's Disease for Induction Remission
Mesalazine, Tripterygium glycosides - Inflammatory Bowel Diseases, Crohn's Disease
Phase 2 / Phase 3UnknownZhu Weiming402014-01-012014-01-24

Showing 20 of 34. Sign in to see all of them.

Conditions studied

Colitis, Ulcerative (11)  ·  Inflammatory Bowel Diseases (10)  ·  Irritable Bowel Syndrome (3)  ·  Colorectal Neoplasms (2)  ·  Colorectal Neoplasms, Hereditary Nonpolyposis (2)  ·  Crohn Disease (2)  ·  Diarrhea (2)  ·  Abdominal Pain (1)  ·  Adenoma (1)  ·  Berylliosis (1)  ·  Colitis (1)  ·  Colitis, Microscopic (1)  ·  Colonic Neoplasms (1)  ·  Diabetes Mellitus, Insulin-Dependent, 12 (1)  ·  Digestive System Diseases (1)

Sponsors

Tanta University (5)  ·  Mostafa Bahaa (3)  ·  Alexandria University (2)  ·  Dr. Falk Pharma GmbH (2)  ·  SOFAR S.p.A. (2)  ·  AHS Cancer Control Alberta (1)  ·  Ann-Sofie Backman (1)  ·  Christoph Gasche (1)  ·  Guangzhou First People's Hospital (1)  ·  Hans Törnblom (1)  ·  Icahn School of Medicine at Mount Sinai (1)  ·  Ihab Elsayed Hassan (1)  ·  Institute for Clinical and Experimental Medicine (1)  ·  Kelsey Jones (1)  ·  Mayo Clinic (1)

Countries

Egypt (11)  ·  United States (6)  ·  China (3)  ·  Germany (3)  ·  Sweden (3)  ·  Belgium (2)  ·  Italy (2)  ·  Netherlands (2)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  Denmark (1)  ·  Hungary (1)  ·  Israel (1)  ·  Kenya (1)

Top investigators

Ana Balske, MD, PhD (1)  ·  Ann-Sofie Backman, MD PhD (1)  ·  Baharak Moshiree, MD, MS (1)  ·  Brian Day, PhD (1)  ·  Britta Siegmund, Professor (1)  ·  Dalia R Mohammed ElAfify, Asst.Prof (1)  ·  Dongfeng Chen, doctor (1)  ·  Federico Buffoli, Doctor (1)  ·  Giovanni Barbara, MD (1)  ·  Hussein A ElAmin Hammam, Professor (1)  ·  Judy H Cho, MD (1)  ·  Kelsey DJ Jones, MBBS BA MRCPCH (1)  ·  Lisa A. Maier, M.D., MSPH (1)

Results publications

PMID 16984503, PMID 22605655, PMID 23414061, PMID 23426454, PMID 25189855, PMID 25192498, PMID 29702300, PMID 33188747, PMID 39575188, PMID 40620467, PMID 41128897, PMID 41213710, PMID 41235106, PMID 41330887